Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference17 articles.
1. Hoshino et al. J Clin Immunol. 2015
2. Vorechovsky I, Luo L, Hertz JM, Froland SS, Klemola T, Fiorini M, et al. Mutation pattern in the Bruton’s tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia. Hum Mutat. 1997;9:418–25.
3. Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol. 2006;118:195–200.
4. Maas A, Dingjan GM, Grosveld F, Hendriks RW. Early arrest in B cell development in transgenic mice that express the E41K Bruton’s tyrosine kinase mutant under the control of the CD19 promoter region. J Immunol. 1999;162:6526–33.
5. Aalipour A, Advani RH. Bruton’s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib. Ther Adv Hematol. 2014;5:121–33.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献